Real-world evidence studies indicate that the CareAdvantage Perioperative Efficiency approach yielded improvements for UCSF Health hip and knee procedures, such as reductions in instrument trays (down 57%), number of instruments used (down 29%) and number of open trays (down 46%), leading to an estimated annual cost savings of >$262,000. Though UCSF was already above benchmarks for overall procedure set-up time, the CareAdvantage capability reduced set-up by 3 minutes for hip procedures and 6 for knees.
The CareAdvantage process, administered by Johnson & Johnson Medical Devices Companies (JJMDC), identifies the customer/health system’s needs and objectives pertaining to the delivery of value-based care. This information feeds into an action plan that includes metrics to measure results. The program helps to streamline the path of JJMDC devices through surgical services and sterile processing.
The program is a response to voice of customer. Results from a JJMDC survey revealed that 64% of U.S. health system executive and 56% of O.R. clinician respondents cited perioperative efficiency improvements as operational priorities. Further, three of four respondents believe that perioperative efficiency can improve overall performance, cost and time challenges, with 2/3 of respondents also expecting to gain improvements in patient satisfaction and quality of care.
Johnson & Johnson is the parent company of DePuy Synthes.
Real-world evidence studies indicate that the CareAdvantage Perioperative Efficiency approach yielded improvements for UCSF Health hip and knee procedures, such as reductions in instrument trays (down 57%), number of instruments used (down 29%) and number of open trays (down 46%), leading to an estimated annual cost savings of...
Real-world evidence studies indicate that the CareAdvantage Perioperative Efficiency approach yielded improvements for UCSF Health hip and knee procedures, such as reductions in instrument trays (down 57%), number of instruments used (down 29%) and number of open trays (down 46%), leading to an estimated annual cost savings of >$262,000. Though UCSF was already above benchmarks for overall procedure set-up time, the CareAdvantage capability reduced set-up by 3 minutes for hip procedures and 6 for knees.
The CareAdvantage process, administered by Johnson & Johnson Medical Devices Companies (JJMDC), identifies the customer/health system’s needs and objectives pertaining to the delivery of value-based care. This information feeds into an action plan that includes metrics to measure results. The program helps to streamline the path of JJMDC devices through surgical services and sterile processing.
The program is a response to voice of customer. Results from a JJMDC survey revealed that 64% of U.S. health system executive and 56% of O.R. clinician respondents cited perioperative efficiency improvements as operational priorities. Further, three of four respondents believe that perioperative efficiency can improve overall performance, cost and time challenges, with 2/3 of respondents also expecting to gain improvements in patient satisfaction and quality of care.
Johnson & Johnson is the parent company of DePuy Synthes.
Copy to clipboard 
